Scholarlink

<p>Pharmacotherapy for paediatric obesity is a rapidly evolving field. In Italy, the medications available for adolescents are semaglutide and liraglutide, which have shown significant efficacy, despite having some limitations, such as the lack of long-term data, gastrointestinal side effects, the risk of rebound after discontinuation and the cost for the families. Setmelanotide is only used for certain specific conditions. Other medications are currently being studied.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novità sulle terapie farmacologiche per l’obesità pediatrica

  • 期刊论文

  • 发表日期：

    2025年6月30日

查看全文
  • Raffaele Buganza,
  • Giulia Massini

摘要

Pharmacotherapy for paediatric obesity is a rapidly evolving field. In Italy, the medications available for adolescents are semaglutide and liraglutide, which have shown significant efficacy, despite having some limitations, such as the lack of long-term data, gastrointestinal side effects, the risk of rebound after discontinuation and the cost for the families. Setmelanotide is only used for certain specific conditions. Other medications are currently being studied.